{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:37:14Z","timestamp":1780403834987,"version":"3.54.1"},"reference-count":98,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100015086","name":"AOP Orphan Pharmaceuticals AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015086","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To present the Central European Myeloproliferative Neoplasm Organisation (CEMPO) treatment recommendations for polycythaemia vera (PV).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>During meetings held from 2015 through 2017, CEMPO discussed PV and its treatment and recent data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PV is associated with increased risks of thrombosis\/thrombo\u2010haemorrhagic complications, fibrotic progression and leukaemic transformation. Presence of <jats:italic>Janus kinase (JAK)\u20102<\/jats:italic> gene mutations is a diagnostic marker and standard diagnostic criterion. World Health Organization 2016 diagnostic criteria for PV, focusing on haemoglobin levels and bone marrow morphology, are mandatory. PV therapy aims at managing long\u2010term risks of vascular complications and progression towards transformation to acute myeloid leukaemia and myelodysplastic syndrome. Risk stratification for thrombotic complications guides therapeutic decisions. Low\u2010risk patients are treated first line with low\u2010dose aspirin and phlebotomy. Cytoreduction is considered for low\u2010risk (phlebotomy intolerance, severe\/progressive symptoms, cardiovascular risk factors) and high\u2010risk patients. Hydroxyurea is suspected of leukaemogenic potential. IFN\u2010\u03b1 has demonstrated efficacy in many clinical trials; its pegylated form is best tolerated, enabling less frequent administration than standard interferon. Ropeginterferon alfa\u20102b has been shown to be more efficacious than hydroxyurea. <jats:italic>JAK<\/jats:italic>1\/<jats:italic>JAK<\/jats:italic>2 inhibitor ruxolitinib is approved for hydroxyurea resistant\/intolerant patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Greater understanding of PV is serving as a platform for new therapy development and treatment response predictors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.13156","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T07:25:22Z","timestamp":1532935522000},"page":"654-664","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recommendations for the diagnosis and treatment of patients with polycythaemia vera"],"prefix":"10.1111","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-9156","authenticated-orcid":false,"given":"Ant\u00f3nia","family":"Hatalova","sequence":"first","affiliation":[{"name":"Clinic of Hematology and Blood Transfusion, University Hospital, Faculty of Medicine, Medical School Comenius University Slovak Medical University Bratislava Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Clinical Section, Institute of Hematology and Blood Transfusion, Institute of Clinical and Experimental Hematology Charles University Prague Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Gotic","sequence":"additional","affiliation":[{"name":"Clinic for Hematology Clinical Center of Serbia Medical Faculty University of Belgrade Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Penka","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology Masaryk University Hospital Brno Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikulas","family":"Hrubisko","sequence":"additional","affiliation":[{"name":"Clinic of Hematology and Blood Transfusion, University Hospital, Faculty of Medicine, Medical School Comenius University Slovak Medical University Bratislava Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajko","family":"Kusec","sequence":"additional","affiliation":[{"name":"Department of Hematology Dubrava University Hospital, University of Zagreb Medical School Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Egyed","sequence":"additional","affiliation":[{"name":"Department of Hematology Somogy County M\u00f3r Kaposi General Hospital Kaposv\u00e1r Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Griesshammer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Palliative Medicine Johannes Wesling Academic Medical Center Minden Germany"},{"name":"University Clinic for Hematology, Oncology and Palliative Medicine, Johannes Wesling Medical Center Minden University of Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Podolak\u2010Dawidziak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wr\u00f3claw Medical University Wr\u00f3claw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Hellmann","sequence":"additional","affiliation":[{"name":"Department of Hematology and Transplantology Medical University Hospital Gda\u0148sk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy","family":"Klymenko","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics State Institution National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine Kyiv Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Niculescu\u2010Mizil","sequence":"additional","affiliation":[{"name":"Provita Diagnosis and Treatment Center Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petro E.","family":"Petrides","sequence":"additional","affiliation":[{"name":"Hematology Oncology Center Munich Ludwig\u2010Maximilian\u2019s University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Grosicki","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention, Public School of Health Silesian Medical University Katowice Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matjaz","family":"Sever","sequence":"additional","affiliation":[{"name":"Department of Hematology University Clinical Center Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Cantoni","sequence":"additional","affiliation":[{"name":"Division of Hematology University Clinic of Medicine Kantonsspital Aarau Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Thiele","sequence":"additional","affiliation":[{"name":"Institute of Pathology University of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Hematology &amp; Oncology Innsbruck Medical University Innsbruck Austria"},{"name":"Medical Clinic 3, Oncology, Hematology and Rheumatology University Hospital of Bonn Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0295-7629","authenticated-orcid":false,"given":"Heinz","family":"Gisslinger","sequence":"additional","affiliation":[{"name":"Division of Hematology and Blood Coagulation, Department of Internal Medicine I Medical University of Vienna Hospital Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23895"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23690"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.163"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371328"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13812"},{"issue":"1","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/asheducation-2015.1.340","article-title":"Management of symptoms in polycythemia vera and essential thrombocythemia patients","volume":"2015","author":"Radia D","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-579136"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0349"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1898"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666151207111707"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-554634"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404810"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05535.x"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06741.x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-009-0005-6"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.151770"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.30.6.771"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094276"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083501"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23585"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.35"},{"issue":"3","key":"e_1_2_10_26_1","first-page":"213","article-title":"The rise and fall of red cell mass measurement in polycythemia vera","volume":"4","author":"Tefferi A","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-292102"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.148"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115009"},{"key":"e_1_2_10_30_1","first-page":"317","article-title":"Diagnostic impact of bone marrow histopathology in polycythemia vera (PV)","volume":"20","author":"Thiele J","year":"2005","journal-title":"Histol Histopathol"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.64"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-393819"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.129155"},{"key":"e_1_2_10_34_1","unstructured":"NagallaS.Polycythemia vera clinical presentation.https:\/\/emedicine.medscape.com\/article\/205114-clinical#showall. Accessed December 15 2014."},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-551929"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1552969.x"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.253"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10634"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06674.x"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23417"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2357-4"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-591610"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.062"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12117"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.556"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12554"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-752600"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-042515"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24583"},{"key":"e_1_2_10_50_1","unstructured":"European Commission.The 2015 ageing report. Underlying assumptions and projection methodologies. European Economy 8;2014.https:\/\/ec.europa.eu\/economy_finance\/publications\/european_economy\/2014\/pdf\/ee8_en.pdf. Accessed March 21 2017."},{"key":"e_1_2_10_51_1","unstructured":"Eurostat.Population structure and ageing(Data extracted June 2016).https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php\/Population_structure_and_ageing. Accessed March 21 2017."},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404854"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404724"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1477"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-046342"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4261"},{"issue":"2","key":"e_1_2_10_57_1","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk PD","year":"1986","journal-title":"Semin Hematol"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.00359.x"},{"key":"e_1_2_10_59_1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand\u2019s disease in the myeloproliferative syndromes","volume":"64","author":"Budde U","year":"1984","journal-title":"Blood"},{"issue":"9","key":"e_1_2_10_60_1","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V90.9.3370","article-title":"Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years","volume":"90","author":"Najean Y","year":"1997","journal-title":"Blood"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10153"},{"issue":"3","key":"e_1_2_10_62_1","first-page":"408","article-title":"Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study","volume":"90","author":"Gisslinger H","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_10_63_1","volume-title":"GeneReviews\u00ae","author":"Kujovich JL","year":"1993"},{"key":"e_1_2_10_64_1","volume-title":"GeneReviews\u00ae","author":"Kujovich JL","year":"1993"},{"key":"e_1_2_10_65_1","first-page":"189","article-title":"Diagnosis and treatment of BCR\/ALB\u2010negative myeloproliferative diseases \u2013 principles and rationale of CZEMP recommendations","volume":"57","author":"Schwarz J","year":"2011","journal-title":"Vnit\u0159 L\u00e9k"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24098"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23474"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.8436"},{"issue":"1","key":"e_1_2_10_69_1","first-page":"s75","article-title":"Current applications of therapeutic phlebotomy","volume":"12","author":"Assi TB","year":"2014","journal-title":"Blood Transfus"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-009-9180-5"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2014.07.003"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.893310"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208500"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03289.x"},{"key":"e_1_2_10_75_1","first-page":"5271","article-title":"Examining the frequency of phlebotomy in patients with polycythemia vera (PV) in the United States: an analysis of data from the REVEAL study","volume":"130","author":"Boccia RV","year":"2017","journal-title":"Blood"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035572"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02997.x"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537100310001646969"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3426"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.0792"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10375"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08019.x"},{"issue":"8","key":"e_1_2_10_83_1","first-page":"989","article-title":"Diagnosis and treatment of thrombocythemia in myeloproliferative disorders","volume":"15","author":"Gilbert HS","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(98)00143-0"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.03.005"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143537"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-442012"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.280"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-637280"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-942761"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23928"},{"key":"e_1_2_10_92_1","first-page":"320","article-title":"Ropeginterferon alpha\u20102 b induces high rates of clinical, hematological and molecular responses in polycythemia vera: two\u2010year results from the first prospective randomized controlled trial","volume":"130","author":"Gisslinger H","year":"2017","journal-title":"Blood"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2152-7"},{"key":"e_1_2_10_94_1","first-page":"520","article-title":"Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders","volume":"89","author":"Birgeg\u00e5rd G","year":"2004","journal-title":"Hematologica"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.10.002"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1036029"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-263319"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28441"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409002"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.13156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T14:57:18Z","timestamp":1694876238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.13156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/ejh.13156"],"URL":"https:\/\/doi.org\/10.1111\/ejh.13156","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"2018-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}